LexDanaLexDanabeta
Inventor

Akio Kanatani

Inventor
Tsukuba, JP

Overview

46→
Patents
2000–2012
Patent span
Human necessities
Primary field (CPC A)

Patents· 46 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds46%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations39%
A61KPreparations for medical, dental or toiletry purposes12%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms1%
G01NInvestigating or analysing materials by determining their chemical or physical properties1%
PatentTitleYear
8,268,842'Fused ring 4-oxopyrimidine derivative'20128,044,070'Heteroaryloxy nitrogenous saturated heterocyclic derivative'20117,960,394'Quinazoline derivative'20117,834,182'Piperidine derivative'20107,803,807'Benzimidazole derivatives'20107,790,731'Crystal form of 2-methyl-3-{4-[3-(1-pyrrolidinyl)propoxy]phenyl}-5-trifluoromethyl-4(3H)-quinazolinone'20107,732,456'Pyridone derivative'20107,727,998'Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient'20107,691,860'Sulfonamide derivatives'20107,687,514'Benzimidazole derivatives'20107,645,756'Nitrogenous fused heteroaromatic ring derivative'20107,595,316'Heteroaryloxy nitrogenous saturated heterocyclic derivative'20097,589,096'Azole derivatives'20097,566,781'Imidazopyridine compound'20097,547,693'Piperidine derivative'20097,541,477'Antagonists to melanin-concentrating hormone receptor comprising benzimidazole derivative as active ingredient'20097,531,668'2-arylcarboxamide-nitrogenous heterocycle compound'20097,521,455'Fused ring 4-oxopyrimidine derivative'20097,510,833'Method for examining obesity or leanness'20097,504,412'Imidazopyridine derivatives'20097,485,647'2-aminoquinoline derivatives'20097,482,358'Imidazoline compounds'20097,365,079'Azole derivatives'20087,304,072'Spiro compounds'20077,138,525'N-substituted-2-oxodihydropyridine derivatives'20067,119,107'Pyridone derivatives'20067,105,526'Benzimidazole derivatives'20067,064,142'Imidazonline compounds'20066,869,966'N-substituted-2-oxodihydropyridine derivatives'20056,803,372'Spiro compounds'20046,723,847'Spiro compounds'20046,649,624'Spiro compounds'20036,638,942'Spiro-indolines as Y5 receptor antagonists'20036,495,559'NPY Y5 receptor antagonists'20026,462,053'Spiro compounds'20026,388,077'Spiro compounds'20026,335,345'Spiro compounds'20026,326,375'Spiro compounds'20016,313,298'Spiro-indolines as Y5 receptor antagonists'20016,258,837'Neuropeptide Y receptor antagonist'20016,191,160'Spiro-indolines as Y5 receptor antagonists'20016,180,653'Aminopyrazole derivatives'20016,166,038'Aminopyrazole derivatives'20006,057,335'Pyrazole derivatives'20006,043,246'Urea derivatives'20006,011,039'Aminopyridine derivatives'2000

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2000–2011Patents assigned to BANYU PHARMA CO LTD (43)· patent assignee history
2000–2012Based in Tsukuba, JP· patent location history
2001–2003Patents assigned to MERCK & CO INC (4)· patent assignee history
2001–2003Based in Ibaraki, JP· patent location history
2009–2011Based in Ushiku, JP· patent location history
2009Based in Tsukkuba, JP· patent location history
2011–2012Patents assigned to MSD KK (2)· patent assignee history
2012Patents assigned to KANATANI AKIO (1)· patent assignee history
2012Patents assigned to NAGASE TSUYOSHI (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
BANYU PHARMA CO LTD432000–2011
MERCK & CO INC42001–2003
MSD KK22011–2012
KANATANI AKIOself12012
NAGASE TSUYOSHI12012
Locations
LocationPatentsSpan
Tsukuba, JP272000–2012
Ushiku, JP142009–2011
Ibaraki, JP42001–2003
Tsukkuba, JP12009